Results 171 to 180 of about 4,013,120 (347)

Investigation and Application of a New Passive Sampling Technique for in Situ Monitoring of Illicit Drugs in Waste Waters and Rivers.

Environmental Science and Technology, 2017
Changsheng Guo, Tingting Zhang, S. Hou, Jiapei Lv, Y. Zhang, Fengchang Wu, Z. Hua, W. Meng, Hao Zhang, Jian Xu   +9 more
semanticscholar   +1 more source

Stable Price Dispersion under Heterogeneous Buyer Consideration

The RAND Journal of Economics, EarlyView.
ABSTRACT We study the pricing of homogeneous products sold to customers who consider different sets of suppliers. We identify prices that are stable in the sense that no firm wishes to undercut a rival or to raise its price when rivals are able to respond by offering special deals.
David P. Myatt, David Ronayne
wiley   +1 more source

Prevalence of Licit and Illicit Drugs Use during Pregnancy in Mexican Women. [PDF]

Pharmaceuticals (Basel), 2022
Gómez-Ruiz LM, Marchei E, Rotolo MC, Brunetti P, Mannocchi G, Acosta-López A, Ramos-Gutiérrez RY, Varela-Busaka MB, Pichini S, Garcia-Algar O.   +9 more
europepmc   +1 more source

Influence of Sex and Diagnosis on Clinical Variables and Neurocognitive Performance in Severe Mental Illness. Results From the PsyCourse Study

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction Bipolar disorder (BD) and schizophrenia (SZ) are serious mental illnesses (SMI) with overlapping symptoms but distinct differences in onset and course. Sex differences are an area of growing interest in SMI. This study aims to examine potential interactions between sex and diagnosis across a broad range of variables, to compare ...
Maria Serra‐Navarro, Maria Heilbronner, Brisa Solé, Roger Borràs, Anabel Martinez‐Arán, Kristina Adorjan, Alba Navarro‐Flores, Mojtaba Oraki Kohshour, Daniela Reich‐Erkelenz, Eva C. Schulte, Fanny Senner, Ion‐George Anghelescu, Volker Arolt, Bernhard T. Baune, Udo Dannlowski, Detlef E. Dietrich, Andreas J. Fallgatter, Christian Figge, Markus Jäger, Georg Juckel, Carsten Konrad, Jens Reimer, Eva Z. Reininghaus, Max Schmauß, Andrea Schmitt, Carsten Spitzer, Jens Wiltfang, Jörg Zimmermann, Sergi Papiol, Urs Heilbronner, Peter Falkai, Thomas G. Schulze, Eduard Vieta, Carla Torrent, Monika Budde, Silvia Amoretti   +35 more
wiley   +1 more source

Illicit drugs - infections and neonatal anthropometric characteristics. [PDF]

Germs
Năstase L, Stoicescu SM, Suciu N, Bohîlţea LC, Panaitescu E, Baciu AB.   +5 more
europepmc   +1 more source

Population Size Estimation of People Who Use Illicit Drugs and Alcohol in Iran (2015-2016). [PDF]

Int J Health Policy Manag, 2023
Rastegari A, Baneshi MR, Hajebi A, Noroozi A, Karamouzian M, Shokoohi M, Mirzazadeh A, Khojasteh Bojnourdi T, Nasiri N, Haji Maghsoudi S, Haghdoost AA, Sharifi H.   +11 more
europepmc   +1 more source

Psilocybin‐assisted psychotherapy for methamphetamine use disorder: A pilot open‐label safety and feasibility study

Addiction, EarlyView.
Abstract Background & Aims There are few effective treatments for methamphetamine use disorder, despite increasing global demand. Here, we assessed the safety and feasibility of outpatient psilocybin‐assisted psychotherapy for methamphetamine use disorder. Design Single arm, open label pilot study.
Elizabeth Knock, Krista J. Siefried, Gill Bedi, Steven Albert, Richard O. Day, Nadine Ezard, Margaret Ross, Paul Liknaitzky, Jonathan Brett   +8 more
wiley   +1 more source

Noncovalent Interaction-Based Probe Design for PET-Facilitated Fluorescence Sensing of Synthetic Cannabinoids

ACS Omega
Jiahao Dong, Chuanfang Zhao, Jinliang Ning, Yuan Liu, Xincun Dou   +4 more
doaj   +1 more source

New Imaging Features of Multinodular and Vacuolating Neuronal Tumor Revealed by Alcohol and Illicit Drugs Consumption. [PDF]

Diagnostics (Basel), 2022
Sirbu CA, Ștefani C, Tuță S, Manole AM, Sirbu OM, Ivan R, Toma GS, Calu AG, Jianu DC.   +8 more
europepmc   +1 more source

Evaluating the optimal duration of medication treatment for opioid use disorder

Addiction, EarlyView.
Abstract Background and aims Clinicians have little guidance on the ideal length of time patients should remain on medication treatment for opioid use disorder (MOUD) before being able to safely discontinue MOUD. This study estimated how the risk of all‐cause mortality changes with the duration of MOUD, controlling for patient characteristics that ...
Corey J. Hayes, Rebecca A. Raciborski, Mahip Acharya, Nahiyan Bin Noor, Edward V. Nunes, T. John Winhusen   +5 more
wiley   +1 more source